FDA panel approves OTC sale of birth control pill.

An FDA advisory panel has unanimously recommended that the birth control pill Opill be sold over the counter in the US, paving the way for its likely approval. If approved, Opill will be the first contraceptive pill to be sold over the counter in the US. The decision comes after medical organizations and advocates for increasing access to birth control have pushed for over-the-counter birth control pills to be available in the US for years. Hormone-based pills, like Opill, have long been among the most common forms of birth control nationwide and have been used by tens of millions of people since the 1960s.